0001140361-14-026587.txt : 20140627
0001140361-14-026587.hdr.sgml : 20140627
20140624181823
ACCESSION NUMBER: 0001140361-14-026587
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140620
FILED AS OF DATE: 20140624
DATE AS OF CHANGE: 20140624
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Echo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001031927
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411649949
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 215-717-4100
MAIL ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020702
FORMER COMPANY:
FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/
DATE OF NAME CHANGE: 20020701
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANDESMAN URI
CENTRAL INDEX KEY: 0001120642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 14938376
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10169
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Platinum-Montaur Life Sciences, LLC
CENTRAL INDEX KEY: 0001404598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 14938377
BUSINESS ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (212) 582-2222
MAIL ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Platinum Partners Liquid Opportunity Master Fund L.P.
CENTRAL INDEX KEY: 0001476165
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 14938379
BUSINESS ADDRESS:
STREET 1: 152 WEST 57 STREET, 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-271-7866
MAIL ADDRESS:
STREET 1: 152 WEST 57 STREET, 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Platinum Management (NY) LLC
CENTRAL INDEX KEY: 0001368616
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 14938381
BUSINESS ADDRESS:
STREET 1: 152 WEST 57TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-581-2401
MAIL ADDRESS:
STREET 1: 152 WEST 57TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nordlicht Mark
CENTRAL INDEX KEY: 0001339643
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 14938382
MAIL ADDRESS:
STREET 1: 159 WYKAGL TERRACE
CITY: NEW ROCHELLE
STATE: NY
ZIP: 10804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Platinum Partners Value Arbitrage Fund, LP
CENTRAL INDEX KEY: 0001299265
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 14938378
BUSINESS ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-581-0500
MAIL ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Platinum Liquid Opportunity Management (NY) LLC
CENTRAL INDEX KEY: 0001582140
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 14938380
BUSINESS ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (212) 582-2222
MAIL ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
4
1
doc1.xml
FORM 4
X0306
4
2014-06-20
0
0001031927
Echo Therapeutics, Inc.
ECTE
0001339643
Nordlicht Mark
152 WEST 57TH STREET
4TH FLOOR
NEW YORK
NY
10019
0
0
1
0
0001368616
Platinum Management (NY) LLC
152 WEST 57TH STREET
4TH FLOOR
NEW YORK
NY
10019
0
0
1
0
0001582140
Platinum Liquid Opportunity Management (NY) LLC
152 WEST 57TH STREET
4TH FLOOR
NEW YORK
NY
10019
0
0
1
0
0001476165
Platinum Partners Liquid Opportunity Master Fund L.P.
152 WEST 57 STREET, 4TH FLOOR
NEW YORK
NY
10019
0
0
1
0
0001299265
Platinum Partners Value Arbitrage Fund, LP
C/O WALKERS CORPORATE SERVICES LIMITED
WALKER HOUSE, 87 MARY STREET
GEORGETOWN, GRAND CAYMAN
E9
KY1-9002
CAYMAN ISLANDS
0
0
1
0
0001404598
Platinum-Montaur Life Sciences, LLC
152 WEST 57TH STREET
4TH FLOOR
NEW YORK
NY
10019
0
0
1
0
0001120642
LANDESMAN URI
30 00 47TH AVE
LONG ISLAND CITY
NY
11101
0
0
1
0
Common Stock
2014-06-20
4
P
0
16490
2.1996
A
594942
I
By Platinum Partners Liquid Opportunity Master Fund L.P.
Common Stock
2014-06-23
4
P
0
85
2.2
A
595027
I
By Platinum Partners Liquid Opportunity Master Fund L.P.
Common Stock
2014-06-24
4
P
0
386
2.2
A
595413
I
By Platinum Partners Liquid Opportunity Master Fund L.P.
Common Stock
1605424
I
By Platinum Partners Value Arbitrage Fund L.P.
This Form 4 is filed jointly by Platinum Partners Value Arbitrage Fund L.P. ("PPVA"), Platinum Partners Liquid Opportunity Master Fund L.P. ("PPLO"), Platinum-Montaur Life Sciences, LLC ("Platinum-Montaur"), Platinum Management (NY) LLC ("Platinum Management"), Platinum Liquid Opportunity Management (NY) LLC ("Platinum Liquid Management"), Mark Nordlicht and Uri Landesman (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein except to the extent of his or its pecuniary interest therein.
Securities owned directly by PPLO. Each of Platinum Liquid Management, as the Investment Manager of PPLO, and Mark Nordlicht and Uri Landesman, as the Chief Investment Officer and President, respectively, of Platinum Liquid Management, may be deemed to beneficially own the securities owned directly by PPLO.
Securities owned directly by PPVA. Each of Platinum Management, as the Investment Manager of PPVA, and Mark Nordlicht and Uri Landesman, as the Chief Investment Officer and President, respectively, of Platinum Management, may be deemed to beneficially own the securities owned directly by PPVA.
/s/ Mark Nordlicht
2014-06-24
Platinum Partners Value Arbitrage Fund L.P., By Platinum Management (NY) LLC, as Investment Manager, By /s/ Mark Nordlicht, Chief Investment Officer
2014-06-24
Platinum Partners Liquid Opportunity Master Fund L.P., By Platinum Liquid Opportunity Management (NY) LLC, as Investment Manager, By /s/ Mark Nordlicht, Chief Investment Officer
2014-06-24
Platinum-Montaur Life Sciences, LLC, By Platinum Management (NY) LLC, as Investment Manager, By /s/ Mark Nordlicht, Chief Investment Officer
2014-06-24
Platinum Management (NY) LLC, By /s/ Mark Nordlicht, Chief Investment Officer
2014-06-24
Platinum Liquid Opportunity Management (NY) LLC, By /s/ Mark Nordlicht, Chief Investment Officer
2014-06-24
/s/ Uri Landesman
2014-06-24